As it has been proposed that TNFα and IFNα signaling pathways cross-regulate each other (68–71), EGA treatment might be beneficial by suppressing both IFNα and TNFα in autoimmunity, although this remains to be adequately determined (71). Here, TNF is linked to Autoimmunity.